---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-044690"
form_type: "8-K"
ticker: "NTLA"
cik: "0001652130"
company_name: "Intellia Therapeutics, Inc."
filed_at: "2024-02-23T23:59:59+00:00"
generated_at: "2026-06-05T17:10:36.727278+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Intellia Therapeutics expands ATM equity facility from $400M to $750M

## Summary
- Intellia increased at-the-market equity offering facility from $400M to $750M via amendment to Jefferies Sales Agreement.
- As of 2/23/24, ~$374M of shares sold; additional $350M authorized under new prospectus supplement.
- Remaining unsold shares under existing prospectus: ~$25.7M.
- Jefferies LLC continues as sales agent, receiving 3.0% of gross proceeds.

## SEC filing metadata
- accession: 0001193125-24-044690
- form_type: 8-K
- ticker: NTLA
- cik: 0001652130
- company_name: Intellia Therapeutics, Inc.
- filed_at: 2024-02-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1652130/000119312524044690/0001193125-24-044690-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1652130/000119312524044690/d762897d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-044690
- JSON: https://secwatch.observer/filing/0001193125-24-044690.json
- Plain text: https://secwatch.observer/filing/0001193125-24-044690.txt

## Key facts
- Material Agreements
  Intellia Therapeutics, Inc. amended Sales Agreement with Jefferies LLC valued at increase from $400,000,000 to $750,000,000 (effective 2024-02-23).
  - Action: amendment
  - Agreement: atm program
  - Counterparty: Jefferies LLC
  - Value: increase from $400,000,000 to $750,000,000
  - Effective: 2024-02-23
  source text: On February 23, 2024, the Company entered into an amendment to the Sales Agreement to increase the size of the at-the-market offering program from $400,000,000 to $750,000,000.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1652130/000119312524044690/0001193125-24-044690-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.